Renaissance Investment Group’s Pfizer PFE Stock Holding History

Renaissance Investment Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$220K	Hold	9,150	–	–	0.04%	79
2026 Q1	$257K	Sell	9,150 -2,000	-18%	-$53.2K	0.06%	72
2025 Q4	$278K	Hold	11,150	–	–	0.06%	71
2025 Q3	$284K	Hold	11,150	–	–	0.06%	69
2025 Q2	$270K	Hold	11,150	–	–	0.06%	68
2025 Q1	$283K	Hold	11,150	–	–	0.07%	67
2024 Q4	$296K	Hold	11,150	–	–	0.06%	68
2024 Q3	$323K	Sell	11,150 -205	-2%	-$5.98K	0.07%	72
2024 Q2	$315K	Sell	11,355 -2,000	-15%	-$55.1K	0.07%	70
2024 Q1	$371K	Sell	13,355 -4,100	-23%	-$114K	0.09%	68
2023 Q4	$503K	Buy	17,455 +2,000	+13%	+$60.5K	0.13%	61
2023 Q3	$513K	Sell	15,455 -3,034	-16%	-$107K	0.14%	59
2023 Q2	$678K	Hold	18,489	–	–	0.18%	54
2023 Q1	$754K	Sell	18,489 -600	-3%	-$25.9K	0.21%	54
2022 Q4	$978K	Sell	19,089 -2,354	-11%	-$113K	0.29%	52
2022 Q3	$977K	Buy	21,443 +5,388	+34%	+$262K	0.3%	51
2022 Q2	$842K	Hold	16,055	–	–	0.27%	50
2022 Q1	$776K	Sell	16,055 -3,131	-16%	-$162K	0.23%	53
2021 Q4	$1.13M	Sell	19,186 -2,914	-13%	-$144K	0.27%	47
2021 Q3	$951K	Sell	22,100 -2,951	-12%	-$131K	0.24%	48
2021 Q2	$981K	Hold	25,051	–	–	0.25%	50
2021 Q1	$907K	Sell	25,051 -4,000	-14%	-$142K	0.25%	51
2020 Q4	$1.07M	Sell	29,051 -2,359	-8%	-$86.5K	0.31%	52
2020 Q3	$1.09M	Hold	31,410	–	–	0.36%	45
2020 Q2	$975K	Sell	31,410 -1,634	-5%	-$55.5K	0.36%	47
2020 Q1	$1.02M	Hold	33,044	–	–	0.48%	40
2019 Q4	$1.23M	Hold	33,044	–	–	0.44%	44
2019 Q3	$1.13M	Buy	33,044 +2,035	+7%	+$74K	0.43%	46
2019 Q2	$1.27M	Sell	31,009 -421	-1%	-$16.7K	0.48%	46
2019 Q1	$1.27M	Sell	31,430 -1,128	-3%	-$45.2K	0.52%	45
2018 Q4	$1.35M	Sell	32,558 -86	-0.3%	-$3.57K	0.65%	41
2018 Q3	$1.36M	Sell	32,644 -2,299	-7%	-$88.5K	0.53%	46
2018 Q2	$1.2M	Sell	34,943 -533	-2%	-$18.2K	0.48%	45
2018 Q1	$1.19M	Sell	35,476 -1,296	-4%	-$44.6K	0.48%	45
2017 Q4	$1.26M	Sell	36,772 -988	-3%	-$33.7K	0.5%	43
2017 Q3	$1.28M	Sell	37,760 -21	-0.1%	-$675	0.54%	45
2017 Q2	$1.2M	Sell	37,781 -595	-2%	-$18.8K	0.53%	45
2017 Q1	$1.25M	Sell	38,376 -1,492	-4%	-$47K	0.55%	47
2016 Q4	$1.23M	Sell	39,868 -676	-2%	-$20.6K	0.58%	48
2016 Q3	$1.3M	Buy	40,544 +44	+0.1%	+$1.47K	0.62%	48
2016 Q2	$1.35M	Buy	40,500 +237	+0.6%	+$7.56K	0.67%	42
2016 Q1	$1.13M	Sell	40,263 -666	-2%	-$19K	0.57%	47
2015 Q4	$1.25M	Buy	40,929 +34	+0.1%	+$1.07K	0.61%	45
2015 Q3	$1.22M	Hold	40,895	–	–	0.63%	45
2015 Q2	$1.3M	Sell	40,895 -2,214	-5%	-$72.2K	0.61%	46
2015 Q1	$1.42M	Sell	43,109 -3,327	-7%	-$106K	0.66%	44
2014 Q4	$1.37M	Hold	46,436	–	–	0.65%	44
2014 Q3	$1.3M	Sell	46,436 -3,162	-6%	-$88.7K	0.63%	46
2014 Q2	$1.4M	Buy	49,598 +527	+1%	+$15K	0.68%	47
2014 Q1	$1.5M	Hold	49,071	–	–	0.76%	45
2013 Q4	$1.43M	Hold	49,071	–	–	0.72%	47
2013 Q3	$1.34M	Buy	49,071 +949	+2%	+$25.8K	0.74%	47
2013 Q2	$1.28M	Buy	+48,122	New	+$1.33M	0.73%	45

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Renaissance Investment Group's PFE Position: Q2 2026 in Review

Renaissance Investment Group held its Pfizer (PFE) position steady in Q2 2026 at 9,150 shares worth $220K. The position accounts for 0.04% of the portfolio, ranked #79.

Renaissance Investment Group first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.5M in Q1 2014. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Renaissance Investment Group held 9,150 shares of Pfizer worth $220K as of Q2 2026.
Renaissance Investment Group left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.04% of Renaissance Investment Group's portfolio in Q2 2026, its #79 holding.
Renaissance Investment Group first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Renaissance Investment Group's Pfizer position peaked at $1.5M in Q1 2014.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Renaissance Investment Group's 13F filing for Q2 2026, filed 8 Jul 2026.